LY2608204

DRUG2 trials

Sponsors

Eli Lilly and Company

Conditions

Diabetes Mellitus, Type 2

Phase 1

A Study of LY2608204 in Patients With Type 2 Diabetes

CompletedNCT01247363

Eli Lilly and CompanyDiabetes Mellitus, Type 2

Start: 2010-11-30End: 2011-03-31Updated: 2018-11-16

Phase 2

A Study in Patients With Type 2 Diabetes

WithdrawnNCT01408095

Eli Lilly and CompanyDiabetes Mellitus, Type 2

Start: 2011-09-30End: 2012-09-30Target: 240Updated: 2011-08-25